AzTrials
AzTrials

Back Painchron_painNCT02600663

Identification of Patients at Risk of Chronic Back Pain Using Questionnaires

An observational study of Back Pain, run by Swiss Paraplegic Research, Nottwil at 1 site in Switzerland.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Patients with acute back pain (<6 weeks) presenting at their general practitioner will be enrolled. Patients fulfilling all inclusion criteria and showing no exclusion criteria will fill out the Heidelberg short questionnaire (HKF-R10) and the Keele STarT Back Screening Tool. Read more about this study

Who is it for?
Ages 20 to 60 years
Conditions the study is for
Back Pain
How many people
16 participants
Where
1 siteSwitzerland
Study dates
1 Apr 2016to 14 Oct 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: patients with acute back pain presenting at the general pratcioner

Who may be able to join

  • acute (<6 weeks) back pain
  • >20 und <60 years of age
  • good oral and written knowledge of German language

Who cannot join

  • any treatment for back pain within the last 6 months
  • Cauda equina
  • tumor
  • generalized pain
  • severe systemic illness
  • substance abuse
  • pregnancy

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Swiss Paraplegic Centre

    Nottwil, Canton of Lucerne, 6207

Other trials in Switzerland

About this study

Patients with acute back pain (<6 weeks) presenting at their general practitioner will be enrolled. Patients fulfilling all inclusion criteria and showing no exclusion criteria will fill out the Heidelberg short questionnaire (HKF-R10) and the Keele STarT Back Screening Tool. These two questionnaires categorize back pain patients into individuals at risk of chronic back pain and those not at risk. Furthermore, data concerning pain location, severity, duration and impairment will be collected. Study participants will receive standard care treatment prescribed by their general practitioner. Six months later, study participants will receive a questionnaire in order to collect data concerning their present pain situation. Patients with relevant impairment in their activities of daily living as a result of back pain will be categorized as individuals with chronic back pain. Categorization at six months will be compared with the categorization at presentation.

Conditions
Back Pain
Medical subject headings
Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02600663
Study groupRoleWhat they receive
acute back painNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. risk of chronic back pain determined by Heidelberger short questionnaire score

    Measured: at enrolment

  2. risk of chronic back pain determined by Keele questionnaire

    Measured: at enrolment

Secondary outcomes (5)
  1. numeric rating scale average pain intensity

    Measured: at enrolment, at 6 months

  2. numeric rating scale minimal pain intensity

    Measured: at enrolment, at 6 months

  3. numeric rating scale pain related sleep-loss

    Measured: at enrolment, at 6 months

  4. clothepin-algometry (numeric rating scale)

    Measured: at enrolment

  5. working days missed

    Measured: at enrolment, at 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Nov 2015 (estimated)
  2. Study start1 Apr 2016
  3. Primary completion14 Oct 2019
  4. Study completion14 Oct 2019

Why it stopped: insufficient recruitment

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02600663
Sponsor's protocol ID
2015-10
Acronym
chron_pain
Status last verified
Dec 2019
First submitted
5 Nov 2015
Last updated
10 Dec 2019
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Back Pain, run by Swiss Paraplegic Research, Nottwil at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 10 Dec 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: insufficient recruitment). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

risk of chronic back pain determined by Heidelberger short questionnaire score (time frame: at enrolment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Dec 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in